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Chemistry 
 
Materials and methods. Chemicals were obtained from reputable suppliers used without any 
further purification. Anhydrous solvents were obtained from AcrosealTM or SureSealTM and 
stored under nitrogen. Synthetic-purity solvents dichloromethane (DCM), acetonitrile (CH3CN), 
methanol (MeOH), diethyl ether (Et2O), diisopropyl ether (i-Pr2O), dimethylformamide (DMF) 
and 40–60 petroleum ether (PE) were used. Deuterated solvent for NMR analysis were 
purchased from Sigma-Aldrich. Thin layer chromatography was performed using plates pre-
coated with Si F254, NH2 F254s or RP-18 F254s and visualized using ultraviolet light. Purifications 
were carried out using a Biotage SP4 automated purification system with UV monitoring at 290 
nm and collection at 254 nm. Grace Resolv pre-packed flash cartridges were used for normal 
phase separations. Microwave-assisted synthesis was performed in sealed Biotage microwave 
vials, using the Biotage Initiator Sixty microwave system. 1H and 13C nuclear magnetic 
resonance (NMR) spectra were recorded at 500 MHz and 125 MHz, respectively, using a Bruker 
Advance III 500 spectrometer or at 300 MHz and 75 MHz, respectively on a Bruker Advance 
300 spectrometer. CDCl3, MeOH-d4 or DMSO-d6 were used as solvents. Chemical shift values 
() are reported in parts per million (ppm) and are referenced against TMS (tetramethylsilane); 
multiplicities are indicated by s = singlet, d= doublet, t = triplet, q = quarted, m = multiplet or 
combination thereof; the prefix br = broad was used for broadened peaks. Liquid 
Chromatography-Mass Spectrometry (LC-MS) was carried out on a Waters Acquity UPLC 
system, with PDA and ELSD employing both positive and negative ionization modes. When a 2 
min gradient was used, the sample was eluted on Acquity UPLC BEH C18, 1.7 μm, 2.1  50 
mm, with a flow rate of 0.6 mL/min using 5-95% 0.1% HCOOH in MeCN. High resolution mass 
spectra were measured using a Finnigan MAT 95 XP or Finnigan MAT 900 XLT by the EPSRC 
National Mass Spectrometry Service, University of Wales, Swansea, Singleton Park. Melting 
points were determined using a Stuart Scientific SMP3 apparatus. Fourier Transform Infrared 
(FTIR) spectra were recorded on a Bio-Rad FTS 3000MX diamond ATR apparatus. Ultraviolet 
(UV) absorption data were obtained using a U-2001 Hitachi Spectrophotometer with the sample 
dissolved in ethanol. Compounds submitted for biological evaluation were obtained with a purity 
higher than 95%. Purity was determined using a Waters XTerra RP18, 5 μm (4.6 × 150 mm) 
column eluted at 1 mL/min under both basic (0.1% aq. ammonia and MeCN) and acidic (0.1% 
aq. HCOOH and MeCN) conditions with a gradient of 5-100% over 15 min. 
5-Methyl-2-(propan-2-yl)cyclohexyl nitrite (Menthyl nitrite) was prepared following the 
reported procedure[1] with slight modifications. Product was obtained from L-menthol using 
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NaNO2 in a water/THF mixture and a solution of 4M HCl. The spectroscopic data are consistent 
with those reported.[2]  Rf 0.85 (PE); IR max/cm-1: 2966, 2936, 2881, 1642; 1H-NMR (500 MHz, 
DMSO-d6) (ppm): 0.74 (3H, d, J = 7.0 Hz, CH(CH3)2), 0.86 (3H, d, J = 7.0 Hz, CH(CH3)2), 0.89-
0.91 (1H, m, CH2(H4)), 0.92 (3H, d, J = 6.5 Hz, CHCH3), 1.14-1.24 (2H, m, 1 × CH2(H3) and 1 
× CH2(H6), 1.42-1.49 (1H, m, CH(H2)), 1-59-1.75 (4H, 1 × CH(H5), 1 × CH2(H4), 1 × CH2(H3) 
and 1 × CH(CH3)2), 1.95-2.02 (1H, m, CH2(H6), 5.33 (1H, td, J = 11.2 and 4.5 Hz, CHO); 13C-
NMR (125 MHz, DMSO-d6) (ppm): 15.75, 20.42, 21.81, 22.99, 25.60, 30.95, 33.45, 41.37, 
46.01, 80.09; MS (CI) m/z (%): 139 ([M–HONO+H+]). 
6-(Cyclohexylmethoxy)-2-[(cyclohexylmethyl)sulfanyl]pyrimidin-4-amine (5). To 6-amino-
2-thioxo-2,3-dihydropyrimidin-4(1H)-one 4 (1.00 g, 6.20 mmol) contained in a dry microwave 
vial was added anhydrous DMF (10 mL). Potassium carbonate (5.13 g, 37.2 mmol) and 
(bromomethyl)cyclohexane (2.16 mL, 2.74 g, 15.5 mmol) were added, the mixture was 
degassed with N2 and then heated at 140 ºC by microwave irradiation for 16 min. The solvent 
was removed under reduced pressure and the residue was taken up in water. The product was 
extracted with DCM (3  15 mL). The organic phases were combined, washed with brine and 
dried (MgSO4). The solvent was removed under reduced pressure and the crude product was 
purified by flash chromatography (gradient from 10/90 to 20/80 acetone/PE) to give the title 
compound as a white solid (1.65 g, 79%). Rf 0.45 (20/80 Acetone/PE); m.p. 111-112 oC; UV max 
(EtOH/nm): 253.0, 224.0; IR max/cm-1: 3392, 3293, 2915, 2842; 1H-NMR (500 MHz, DMSO-d6) 
(ppm): 0.90-1.28 (10H, m, 5H × C6H11 and 5 × C6H11), 1.48-1.89 (12H, m, 6H × C6H11 and 6 × 
C6H11), 2.90 (2H, d, J = 6.8 Hz, CH2S), 4.00 (2H, d, J = 6.5 Hz, CH2O), 5.37 (1H, s, CH arom.), 
6.60 (2H, s, NH2); 13C-NMR (125 MHz, DMSO-d6) (ppm): 25.15, 25.57, 25.91, 25.98, 29.15, 
32.09, 36.60, 36.82, 37.58, 70.21, 81.59, 165.12, 168.72, 169.29; MS (ES+) m/z 336.4 [M+H]+. 
6-(Cyclohexylmethoxy)-2-[(cyclohexylmethyl)sulfonyl]pyrimidin-4-amine (6). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)thio)pyrimidin-4-amine 5 (660 mg, 1.97 mmol) in 
DCM (15 mL) 3-chloroperbenzoic acid (1.70 g, 9.85 mmol) was added portionwise. The reaction 
mixture was stirred at room temperature for 17 h. The solvent was removed under reduced 
pressure and the residue was partitioned between water (20 mL) and EtOAc (3  15 mL). The 
combined organic extracts were washed with saturated aq. NaHCO3, brine and dried (MgSO4). 
The crude product was purified by flash chromatography (gradient from 10/90 to 20/80 
acetone/PE) to give the title compound as a white powder (404 mg, 56%). Rf 0.28 (20/80 
Acetone/PE); m.p. 139-140oC; UV max (EtOH/nm): 245.0, 215.8; IR max/cm-1: 3494, 3412, 
2923, 2851, 1364 (S=O), 1136 (S=O); 1H-NMR (500 MHz, DMSO-d6) (ppm): 0.93-1.31 (10H, 
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m, 5H × C6H11 and 5 × C6H11), 1.51-1.93 (12H, m, 6H × C6H11 and 6 × C6H11), 3.34 (2H, d, J = 
6.3 Hz, CH2S), 4.04 (2H, d, J = 6.3 Hz, CH2O), 5.81 (1H, s, CH arom.), 7.34 (2H, s, NH2); 13C-
NMR (125 MHz, DMSO-d6) (ppm): 25.15, 25.25, 25.40, 25.90, 29.03, 31.17, 32.27, 36.76, 
55.83, 71.45, 86.87, 164.66, 166.07, 169.48; MS (ES+) m/z 368 [M+H]+. 
2-{[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}propan-1-ol (7a). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (250 mg, 0.68 mmol) 
contained in a dry microwave vial was added diglyme (3 mL). Ethanolamine (144 µL, 146 mg, 
2.38 mmol) was added, the mixture was degassed with N2 and then heated to 170oC by 
microwave irradiation for 3h. The solvent was removed under reduced pressure and the residue 
was partitioned between water (20 mL) and EtOAc (3  15 mL). The organic extracts were 
washed with brine and dried (MgSO4). The crude product was purified by flash chromatography 
(gradient from 0/100 to 5/95 MeOH/CH2Cl2) to give the title compound as a white solid (118 mg, 
65 %). Rf 0.17 (5/95 MeOH/CH2Cl2); m.p. 74-75 oC; UV max (EtOH/nm): 268.6, 238,2, 208.4; IR 
max/cm-1: 3428, 3322, 3274, 2918, 2851, 1552; 1H-NMR (500 MHz, DMSO-d6) (ppm): 0.90-
1.27 (5H, m, C6H11), 1.59-1.75 (6H, m, C6H11), 3.21-3.27 (2H, m, CH2NH), 3.43-3.48 (2H, m, 
CH2OH), 3.90 (2H, d, J = 6.5 Hz, CH2O), 4.63 (1H, t,  J = 5.4 Hz OH), 5.01 (1H, s, CH arom.), 
6.02 (2H, s, NH2), 6.15 (1H, t,  J = 5.6 Hz, NH); 13C-NMR (125 MHz, DMSO-d6) (ppm): 25.25, 
26.03, 29.30, 36.98, 43.37, 60.37, 69.64, 75.85, 162.04, 165.79, 170.01; MS (ES+) m/z 267 
[M+H]+. 
(2S)-2-{[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}propan-1-ol (7b). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (300 mg, 0.82 mmol) 
contained in a dry microwave vial was added dry THF (2.5 mL). Yb(OSO2CF3)3 (253 mg, 0.41 
mmol) was added followed by (S)-(+)-2-amino-1-propanol (223 µL, 215 mg, 2.86 mmol), the 
mixture was degassed with N2 and then heated to 120oC by microwave irradiation for 30 min. 
The solvent was removed under reduced pressure and the crude product was purified by flash 
chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2) to give the title compound as a 
sticky white solid (60 mg, 26 %). Rf 0.21 (5/95 MeOH/CH2Cl2); UV max (EtOH/nm): 268.6, 238.6, 
208.2; IR max/cm-1: 3334, 3217, 2921, 2849, 1566; 1H-NMR (500 MHz, CDCl3) (ppm): 0.96-
1.04 (2H, m, C6H11), 1.20 (3H, d, J = 6.86 Hz, CH3), 1.13-1.30 (3H, m, C6H11), 1.66-1.81 (6H, m, 
C6H11), 3.56 (1H, dd, J = 10.69 and 7.78 Hz, CH2OH), 3.72 (1H, dd, J = 10.70 and 2.79 Hz, 
CH2OH), 3.91-3.99 (2H, m, CH2O), 4.04-4.11 (1H, m, CH), 4.47 (2H, s, NH2), 4.80 (1H, d,  J = 
5.63 Hz, NH), 5.19 (1H, s, CH arom.); 13C-NMR (125 MHz, CDCl3) (ppm): 17.92, 25.96, 26.65, 
29.97, 37.63, 50.02, 69.91, 71.52, 78.00, 162.56, 164.92, 171.52; MS (ES+) m/z 281 [M+H]+. 
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(2R)-2-{[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}propan-1-ol (7c). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (300 mg, 0.82 mmol) 
contained in a dry microwave vial was added dry THF (2.5 mL). Yb(OSO2CF3)3 (253 mg, 0.41 
mmol) was added followed by (R)-(-)-2-amino-1-propanol (223 µL, 215 mg, 2.86 mmol), the 
mixture was degassed with N2 and then heated to 120oC by microwave irradiation for 30 min. 
The solvent was removed under reduced pressure and the crude product was purified by flash 
chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2) to give the title compound as a 
sticky white solid (33 mg, 14%).Rf 0.21 (5/95 MeOH/CH2Cl2); UV max (EtOH/nm): 269.0, 238.8, 
208.2; IR max/cm-1: 3334, 3213, 2921, 2850, 1568; 1H-NMR (500 MHz, CDCl3) (ppm): 0.94-
1.05 (2H, m, C6H11), 1.19 (3H, d, J = 6.86 Hz, CH3), 1.11-1.30 (3H, m, C6H11), 1.63-1.83 (6H, m, 
C6H11), 3.55 (1H, dd, J = 10.7 and 7.6 Hz, CH2OH), 3.71 (1H, dd, J = 10.7 and 2.7 Hz, CH2OH), 
3.89-3.99 (2H, m, CH2O), 4.02-4.11 (1H, m, CH), 4.53 (2H, s, NH2), 4.88 (1H, d,  J = 5.77 Hz, 
NH), 5.18 (1H, s, CH arom.); 13C-NMR (125 MHz, CDCl3) (ppm): 17.57, 25.80, 26.49, 29.83, 
37.47, 49.31, 68.16, 71.34, 77.45, 162.10, 165.01, 171.24; MS (ES+) m/z 281 [M+H]+. 
(2R)-2-{[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}butan-1-ol (7d). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (200 mg, 0.54 mmol) 
contained in a dry microwave vial dry THF (2.5 mL) was added. Yb(OSO2CF3)3 (169 mg, 0.27 
mmol) was added followed by (R)-(-)-2-amino-1-butanol (180 µL, 170 mg, 1.91 mmol), the 
mixture was degassed with N2 and then heated to 120oC in the oil bath for 24 h. The solvent 
was removed under reduced pressure and the crude product was purified by flash 
chromatography (2/98 MeOH/CH2Cl2) to give the title compound as a white solid (90 mg, 59%). 
Rf 0.24 (5/95 MeOH/CH2Cl2); m.p. 79-80 °C; 1H-NMR (500 MHz, DMSO-d6) (ppm): 0.84 (3H, 
t, J = 7.3 Hz, CH3), 0.90-1.31 (5H, m, C6H11), 1.31-1.47 (1H, m, CH2CH3), 1.50-1.80 (7H, m, 6 × 
C6H11 and 1 × CH2CH3), 3.26-3.46 (2H, m, CH2OH), 3.62-3.80 (1H, m, CHCH2CH3), 3.80-3.99 
(2H, m, CH2O), 4.59 (1H, br. s, OH), 5.00 (1H, s, CH arom.), 5.88 (1H, d, J = 8.4 Hz, NH), 5.99 
(2H, s, NH2); 13C-NMR (125 MHz, CDCl3) (ppm): 10.67, 23.90, 25.33, 26.09, 29.37, 37.03, 
53.45, 63.18, 69.70, 75.81, 161.99, 165.75, 170.00; MS (ES+) m/z 295.5 [M+H]+. 
2-{[4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}-3-methylbutan-1-ol (7e). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (300 mg, 0.82 mmol) 
contained in a dry microwave vial was added diglyme (3 mL). 2-amino-3-methyl-1-butanol (315 
µL, 295 mg, 2.86 mmol) was added, the solution was degassed with N2 and then heated to 170 
oC by microwave irradiation for 12 h. The solvent was removed under reduced pressure and the 
residue was partitioned between water (20 mL) and EtOAc (3  15 mL). The organic extracts 
were washed with brine and dried (MgSO4). The crude product was purified by flash 
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chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2) to give the title compound as a 
white solid (131 mg, 52 %). Rf 0.2 (5/95 MeOH/CH2Cl2); m.p. 110-111 ºC; UV max (EtOH/nm): 
269.4, 239.0, 208.2; IR max/cm-1: 3441, 3341, 3238, 2922, 2850, 1572; 1H-NMR (500 MHz, 
DMSO-d6) (ppm): 0.85 (3H, d, J = 7.1 Hz, CH3), 0.87 (3H, d, J = 7.1 Hz, CH3) 0.90-1.02 (2H, 
m, C6H11), 1.09-1.29 (3H, m, C6H11), 1.59-1.77 (6H, m, C6H11), 1.84-1.94 (1H, m, CHCH3) 3.39-
3.46 (2H, m, CH2OH), 3.69-3.76 (1H, m, CHCH2OH), 3.87 (1H, dd, J = 10.2 and 6.6 Hz, CH2O), 
3.94 (1H, br.s., CH2O), 4.47 (1H, t, J = 5.4 Hz, OH), 5.00 (1H, s, CH arom.), 5.77 (1H, d, J = 8.9 
Hz, NH), 5.95 (2H, s, NH2); 13C-NMR (125 MHz, DMSO-d6) (ppm): 18.47, 19.52, 25.26, 26.04, 
28.53, 29.30, 36.97, 56.80, 61.48, 69.62, 75.76, 162.25, 165.71, 169.93; MS (ES+) m/z 309 
[M+H]+. 
3-{[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]amino}propan-1-ol (7f). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (250 mg, 0.68 mmol) 
contained in a dry microwave vial was added dry THF (2.5 mL). Yb(OSO2CF3)3 (211 mg, 0.34 
mmol) was added followed by 3-amino-1-propanol (201 µL, 179 mg, 2.38 mmol), the solution 
was degassed with N2 and then heated to 120oC by microwave irradiation for 30 min. The solvent 
was removed under reduced pressure and the crude product was purified by flash 
chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2) to give the title compound as a 
white solid (77 mg, 40%). Rf 0.18 (5/95 MeOH/CH2Cl2); m.p. 108-109oC; UV max (EtOH/nm): 
269.0, 238.4, 208.0; IR max/cm-1: 3439, 3334, 3249, 3207, 3095, 2918, 2849, 1574; 1H-NMR 
(500 MHz, CDCl3) (ppm): 0.93-1.07 (2H, m, C6H11), 1.11-1.32 (3H, m, C6H11), 1.62-1.86 (8H, 
m, 6 × C6H11 and 2 × CH2OH), 3.50-3.56 (2H, m, CH2NH), 3.60-3.64 (2H, m, CH2CH2CH2), 3.93 
(2H, d, J = 6.5 Hz, CH2O), 4.47 (2H, s, NH2), 4.90 (1H, t, J = 6.5 Hz, NH) 5.17 (1H, s, CH arom.); 
13C-NMR (125 MHz, CDCl3) (ppm): 25.89, 26.60, 29.92, 33.52, 37.11, 37.56, 58.34, 71.47, 
77.37, 162.94, 165.07, 171.58; MS (ES+) m/z 281 [M+H]+. 
N2-(2-Aminocyclohexyl)-6-(cyclohexylmethoxy)pyrimidine-2,4-diamine (7g). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (400 mg, 1.09 mmol) 
contained in a dry microwave vial was added dry THF (3 mL). Yb(OSO2CF3)3 (68 mg, 0.11 
mmol) was added followed by (±)-trans-1,2-diaminocyclohexane (436 mg, 3.81 mmol) and the 
solution was degassed with N2 then heated to 120 oC by microwave irradiation for 6.5 h. The 
solvent was removed under reduced pressure and the crude product was purified by flash 
chromatography (gradient from 5/95 to 30/70 MeOH/CH2Cl2) to give the title compound as a 
white solid (203 mg, 58 %). Rf 0.23 (10/90 MeOH/CH2Cl2); m.p. 90-91oC; UV max (EtOH/nm): 
266.8, 209.0; IR max/cm-1: 3483, 3432, 3354, 2922, 2851, 1569; 1H-NMR (500 MHz, DMSO-d6) 
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(ppm): 0.85-1.26 (9H, m, 5 × C6H11 and 4 × C6H11), 1.53-1.75 (10H, m, 6 × C6H11 and 4 × 
C6H11), 2.57-2.65 (1H, m, CHNH2), 3.39-3.51 (1H, m, CHNH), 3.81-3.90 (1H, m, CH2O), 3.91-
4.00 (1H, m, CH2O), 4.19 (2H, br. s., NH2), 5.02 (1H, s, CH arom.), 6.02 (2H, s, NH2), 6.22 (1H, 
d, J = 8.1 Hz, NH); 13C-NMR (125 MHz, DMSO-d6) (ppm): 24.52, 24.80, 25.24, 25.76, 26.03, 
29.33, 31.87, 36.95, 53.65, 55.56, 69.71, 75.91, 162.04, 165.75, 169.94; MS (ES+) m/z 320 
[M+H]+. 
tert-Butyl {2-[(4-amino-6-(cyclohexylmethoxy)pyrimidin-2-yl)amino]cyclohexyl} 
carbamate (10). To N2-(2-aminocyclohexyl)-6-(cyclohexylmethoxy)pyrimidine-2,4-diamine 7g 
(230 mg, 0.721 mmol) in dry THF (3 mL) was added di-tert-butyl dicarbonate ((Boc)2O) (173 mg, 
0.793 mmol) at room temperature. After 2 h the reaction was complete and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(gradient from 0/100 to 5/95 MeOH/CH2Cl2) to give the title compound as a white solid (200 mg, 
66 %). Rf 0.24 (5/95 MeOH/CH2Cl2); m.p. 86-87 oC; UV max (EtOH/nm): 269.6, 238.6, 209.0; IR 
max/cm-1: 3343, 3238, 2922, 2851, 1697, 1571; 1H-NMR (500 MHz, DMSO-d6) (ppm): 0.88-
1.27 (9H, m, 5 × C6H11 and 4 × C6H11), 1.55-2.03 (10H, m, 6 × C6H11 and 4 × C6H11), 3.14-3.26 
(1H, m, CHNH), 3.40-3.56 (1H, m, CHNH), 3.79-3.99 (2H, m, CH2O), 5.00 (1H, s, CH arom.), 
5.86 (1H, d, J = 7.2 Hz, NH), 6.02 (2H, s, NH2), 6.66 (1H, d, J = 7.9 Hz, NH); 13C-NMR (125 
MHz, DMSO-d6) (ppm): 24.50, 25.21, 26.03, 28.16, 29.30, 31.87, 36.91, 54.18, 54.49, 69.73, 
75.88, 77.53, 155.88, 161.85, 165.77, 169.87; MS (ES+) m/z 420 [M+H]+. 
2-{1-[4-Amino-6-(cyclohexylmethoxy)pyrimidin-2-yl]piperidin-4-yl}ethan-1-ol (7h). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (200 mg, 0.54 mmol) 
contained in a dry microwave vial was added dry THF (2 mL). Yb(OSO2CF3)3 (169 mg, 0.27 
mmol) was added followed by 4-piperydinethanol (246 mg, 1.91 mmol), the solution was 
degassed with N2 and then heated to 120°C by microwave irradiation for 7 h. The solvent was 
removed under reduced pressure and the crude product was purified by flash chromatography 
(gradient from 1/99 to 2/98 MeOH/CH2Cl2) to give the title compound as a white solid (90 mg, 
49 %). Rf 0.25 (5/95 MeOH/CH2Cl2); m.p. 89-90°C; 1H-NMR (300 MHz, DMSO-d6) (ppm): 
0.84-1.30 (9H, m, 5 × C6H11 and 4 × CH2piperidine), 1.31-1.41 (2H, m, CH2CH2CH), 1.53-1.76 
(7H, m, 6 × C6H11 and 1 × CH piperidine), 2.60-2.76 (2H, m, CH2N), 3.40-3.50 (2H, m, CH2OH), 
3.91 (2H, d, J = 5.8 Hz, CH2O), 4.36 (1H, t, J = 4.7 Hz, OH), 4.47-4.61 (2H, m, CH2N), 5.00 (1H, 
s, CH arom.), 6.06 (2H, s, NH2); 13C-NMR (75 MHz, CDCl3) (ppm): 25.37, 26.07, 29.42, 31.86, 
32.57, 38.61, 40.05, 43.58, 58.24, 69.68, 75.48, 160.94, 165.79, 169.94; MS (ES+) m/z 335 
[M+H]+. 
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6-(Cyclohexylmethoxy)-2-(pyrrolidin-1-yl)pyrimidin-4-amine (7i). To 6-
(cyclohexylmethoxy)-2-((cyclohexylmethyl)sulfonyl)pyrimidin-4-amine 6 (200 mg, 0.54 mmol) 
contained in a dry microwave vial was added dry THF (2 mL). Yb(OSO2CF3)3 (169 mg, 0.27 
mmol) was added followed by pyrrolidine (159 µL, 138 mg, 1.91 mmol), the solution was 
degassed with N2 and then heated to 120ºC by microwave irradiation for 2 h. The solvent was 
removed under reduced pressure and the crude product was purified by flash chromatography 
(gradient from 1/99 to 2/98 MeOH/CH2Cl2) to give the title compound as a white solid (120 mg, 
80%). Rf 0.3 (5/95 MeOH/CH2Cl2); m.p. 140-141 oC; 1H-NMR (300 MHz, DMSO-d6) (ppm): 
0.90-1.27 (5H, m, C6H11), 1.61-1.73 (6H, m, C6H11), 1.81-1.85 (4H, m, CH2CH2 pyrrolidine), 3.34-
3.39 (4H, m, 2 × CH2N pyrrolidine), 3.94 (2H, d, J = 6.0 Hz, CH2O), 5.02 (1H, s, CH arom.), 6.02 
(2H, s, NH2); 13C-NMR (75 MHz, DMSO-d6) (ppm): 24.99, 25.34, 26.07, 29.41, 37.14, 46.04, 
69.52, 75.28, 160.00, 165.74, 169.71; MS (ES+) m/z 277 [M+H]+. 
 
General procedure for synthesis of nitroso derivatives 8. The corresponding 6-
(cyclohexylmethoxy)-N2-pyrimidine-2,4-diamine 7 was dissolved in DMSO and the appropriate 
alkyl nitrite (2.5 eq.) was added at r.t. The reaction mixture was stirred for 24 h when 200 mL of 
H2O were added and product was extracted with EtOAc (3  15 mL). The organic fractions were 
combined, washed with brine and dried (MgSO4). The solvent was removed under reduced 
pressure and the crude product purified by flash chromatography. 
 
2-[(4-Amino-6-cyclohexylmethoxy-5-nitrosopyrimidin-2-yl)amino]ethan-1-ol (8a). 
Prepared starting from 7a (44 mg, 0.165 mmol), using isopentyl nitrite (56 µL, 49 mg, 0.413 
mmol). The crude product was purified by flash chromatography (gradient from 1/99 to 20/80 
MeOH/CH2Cl2) to give the title compound as a purple solid (43 mg, 88 %). Rf 0.2 (5/95 
MeOH/CH2Cl2); m.p. 146-148oC; UV max (EtOH/nm): 339.2, 237.6; IR max/cm-1: 3236, 3144, 
2923, 2852, 1569. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 
2 / 1.
 
1H-NMR (500 MHz, DMSO-d6) (ppm): 0.99-1.32 (10H, m, 5 × C6H11 conformer 1 and 5 
× C6H11 conformer 2), 1.61-1.91 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 conformer 2), 
3.35-3.40 (2H, m, CH2NH conformer 1), 3.41-3.46 (2H, m, CH2NH conformer 2), 3.49-3.57 (4H, 
m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 4.29 (2H, d, J = 6.4 Hz, CH2O 
conformer 1), 4.35 (2H, d, J = 6.4 Hz, CH2O conformer 2), 4.70-4.76 (2H, m, 1 × OH conformer 
1 and 1 × OH conformer 2), 7.89 (1H, d, J = 4.4 Hz, NH2 conformer 2), 8.16 (1H, t, J= 5.9 Hz, 
NH conformer 2), 8.19 (1H, d, J = 4.4 Hz, NH2 conformer 1), 8.26 (1H, t, J = 5.8 Hz, NH conformer 
1), 9.93 (1H, d, J = 4.4 Hz, NH2 conformer 2), 10.28 (1H, d, J = 4.4 Hz, NH2 conformer 1); 13C-
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NMR (125 MHz, DMSO-d6) (ppm): conformer 1: 25.14, 25.95, 29.14, 36.69, 43.69, 59.32, 
71.47, 139.54, 150.57, 161.49, 169.94; conformer 2: 25.24, 25.95, 29.20, 36.91, 43.88, 59.70, 
71.55, 139.67, 150.57, 161.93, 170.71; MS (ES+) m/z 296 [M+H]+; HRMS calcd for C13H21N5O3 
[M+H]+296.1717, found 296.1717. 
(2S)-2-[(4-Amino-6-cyclohexylmethoxy-5-nitrosopyrimidin-2-yl)amino]propan-1-ol (8b). 
Prepared starting from 7b (55 mg, 0.196 mmol), using menthyl nitrite (127 mg, 0.687 mmol). 
The crude product was purified by flash chromatography (gradient from 0/100 to 5/95 
MeOH/CH2Cl2) to give the title compound as a purple solid (40 mg, 66%). Rf 0.3 (5/95 
MeOH/CH2Cl2); m.p. 72-74oC; UV max (EtOH/nm): 339.4, 238.0; IR max/cm-1: 3249, 2923, 2851, 
1558. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 / 3, 1H-NMR 
(500 MHz, CDCl3)  (ppm): 1.01-1.34 (16H, m, 5 × C6H11 and 3 × CH3 conformer 1, 5 × C6H11 
and 3 × CH3 conformer 2), 1.53-2.02 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 conformer 
2), 2.84 (2H, br. s, 1 × OH conformer 1 and 1 × OH conformer 2), 3.60-3.68 (2H, m, 1 × CH2OH 
conformer 1 and 1 × CH2OH conformer 2), 3.77 (1H, dd , J = 11.0 and 3.6 Hz, CH2OH conformer 
1), 3.85 (1H, dd , J = 10.7 and 3.0 Hz, CH2OH conformer 2) 4.21-4.28 (1H, m, CHNH conformer 
1), 4.30-4.37 (4H, m, 2 xCH2O conformer 1, 1 × CH2O conformer 2 and 1 × CHNH conformer 
2), 4.41 (1H, dd, J = 10.4 and 6.5 Hz, CH2O conformer 2), 5.59 (1H, br. s, NH2 conformer 1), 
5.81 (1H, d, J = 7.7 Hz, NH conformer 1), 6.00 (1H, br. s, NH2 conformer 2), 6.54 (1H, br. s, NH 
conformer 2), 10.29 (1H, br. s, NH2 conformer 2), 10.61 (1H, br. s, NH2 conformer 1); 13C-NMR 
(125 MHz, CDCl3)  (ppm): conformer 1: 17.33, 25.79, 26.53, 29.88, 37.23, 49.55, 67.23, 73.07, 
140.20, 150.81, 162.23, 171.12; conformer 2: 17.33, 25.86, 26.50, 29.98, 37.45, 49.44, 66.36, 
73.28, 140.07, 151.08, 162.28, 171.80; MS (ES+) m/z 310 [M+H]+; HRMS calcd for C14H23N5O3 
[M+H]+ 310.1874, found 310.1876. 
(2R)-2-[(4-Amino-6-cyclohexylmethoxy-5-nitrosopyrimidin-2-yl)amino]propan-1-ol (8c). 
Prepared starting from 7c (46 mg, 0.164 mmol), using menthyl nitrite (106 mg, 0.575 mmol). 
The crude product was purified by flash chromatography (gradient from 0/100 to 5/95 
MeOH/CH2Cl2) to give the title compound as a purple solid (30 mg, 60%). Rf 0.3 (5/95 
MeOH/CH2Cl2); m.p. 94-96 oC; UV max (EtOH/nm): 339.6, 237.8; IR max/cm-1: 3235, 2920, 
2848, 1563. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 / 3. 
1H-NMR (500 MHz, CDCl3)  (ppm): 1.00-1.35 (16H, m, 5 × C6H11 and 3 × CH3 conformer 1, 5 
× C6H11 and 3 × CH3 conformer 2), 1.65-2.02 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 
conformer 2), 2.58 (1H, br. s, OH conformer 2), 2.78 (1H, br. s, OH conformer 1) 3.61-3.68 (2H, 
m, 1 × CH2OH conformer 1 and 1 × CH2OH conformer 2), 3.77 (1H, dd, J = 10.9 and 3.6 Hz, 
CH2OH conformer 1), 3.84 (1H, dd , J= 10.9 and 3.6 Hz, CH2OH conformer 2) 4.20-4.28 (1H, 
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m, CHNH conformer 1), 4.31-4.37 (4H, m, 2 × CH2O conformer 1, 1 × CH2O conformer 2 and 1 
× CHNH conformer 2), 4.42 (1H, dd, J = 10.4 and 6.6 Hz, CH2O conformer 2) 5.58 (1H, br. s, 
NH2 conformer 1), 5.80 (1H, d, J = 7.6 Hz, NH conformer 1), 5.85 (1H, br. s, NH2 conformer 2), 
6.36 (1H, d, J = 7.6 Hz, NH conformer 2), 10.28 (1H, br. d, J = 4.7 Hz, NH2 conformer 2), 10.61 
(1H, br. s, NH2 conformer 1); 13C-NMR (125 MHz, CDCl3)  (ppm): conformer 1: 17.34, 25.79, 
26.53, 29.88, 37.23, 49.54, 67.25, 73.07, 140.18, 150.75, 162.21, 171.12; conformer 2: 17.34, 
25.87, 26.50, 29.98, 37.46, 49.42, 66.44, 73.29, 140.15, 151.02, 162.31, 171.86; MS (ES+) m/z 
310 [M+H]+; HRMS calcd for C14H23N5O3 [M+H]+ 310.1874, found 310.1875. 
(2R)-2-{[4-Amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino}butan-1-ol (8d). 
Prepared starting from 7d (70 mg, 0.238 mmol), using isopentyl nitrite (80 µL, 70 mg, 0.595 
mmol). The crude product was purified by flash chromatography (2/98 MeOH in CH2Cl2) to give 
the title compound as a purple solid (58 mg, 75 %). Rf 0.27 (5/95 MeOH/CH2Cl2); m.p. 84-86 oC. 
The compound exists as two conformers, conformer 1 / conformer 2 ratio = 2 / 1. 1H-NMR (300 
MHz, DMSO-d6)  (ppm): 0.78-0.92 (6H, m, 3 × CH3 conformer 1 and 3 × CH3 conformer 2), 
0.94-1.34 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 conformer 2), 1.36-1.51 (2H, m, CH2CH3 
conformer 1) 1.54-1.92 (14H, m, 6 × C6H11 conformer 1, 6 × C6H11 and 2 × CH2CH3 conformer 
2), 3.38-3.49 (4H, m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 3.86-4.07 (2H, m, 
1 × CHNH conformer 1 and 1 × CHNH conformer 2), 4.24-4.42 (4H, m, 2 × CH2O conformer 1 
and 2 × CH2O conformer 2), 4.66-4.78 (2H, m, 1 × OH conformer 1, 1 × OH conformer 2), 7.81 
(1H, br. d, J = 4.0 Hz, NH2, conformer 2), 8.00 (1H, d, J = 8.7 Hz, NH, conformer 2), 8.06-8.18 
(2H, m, 1 × NH, conformer 1, 1 × NH2, conformer 1) 9.96 (1H, br. d, J = 4.0 Hz, NH2, conformer 
2), 10.27 (1H, br. d, J = 4.0 Hz NH2, conformer 1); 13C-NMR (75 MHz, DMSO-d6)  (ppm): 
conformer 1: 10.50, 23.53, 25.20, 26.00, 29.19, 36.74, 54.60, 62.60, 71.58, 139.56, 150.75, 
161.63, 169.89; conformer 2: 10.67, 23.86, 25.30, 26.00, 29.19, 36.92, 55.26, 62.97, 71.58, 
139.66, 150.66, 162.10, 170.59; MS (ES+) m/z 324 [M+H]+; HRMS calcd for C15H25N5O3 [M+H]+ 
324.2030, found 324.2044. 
2-{[4-Amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino}-3-methylbutan-1-ol 
(8e). Prepared starting from 7e (70 mg, 0.227 mmol), using menthyl nitrite (147 mg, 0.795 
mmol). The crude product was purified by flash chromatography (gradient from 0/100 to 10/90 
MeOH/CH2Cl2) to give the title compound as a purple solid (43 mg, 56 %). Rf 0.3 (5/95 
MeOH/CH2Cl2); m.p. 176-177 oC; UV max (EtOH/nm): 340.4, 238.4; IR max/cm-1: 3242, 2922, 
2851, 1561. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 / 3. 
1H-NMR (500 MHz, DMSO-d6)  (ppm): 0.83-0.92 (12H, m, 6 × CH3 conformer 1 and 6 × CH3 
conformer 2), 1.00-1.32 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 conformer 2), 1.62-1.95 
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(14H, m, 6 × C6H11 and 1 × CH(CH3)2 conformer 1, 6 × C6H11 and 1 × CH(CH3)2  conformer 2), 
3.43-3.58 (4H, m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 3.87-3.93 (1H, m, 
CHNH conformer 1), 3.95-4.02 (1H, m, CHNH conformer 2), 4.25-4.35 (3H, m, 2 × CH2O 
conformer 1 and 1 × CH2O conformer 2), 4.39 (1H, dd, J = 10.6 and 6.2 Hz, CH2O conformer 
2), 4.57-4.63 (2H, m, 1 × OH conformer 1 and 1 × OH conformer 2), 7.76 (1H, d, J = 4.3 Hz, 
NH2 conformer 2), 8.01 (1H, d, J = 9.2 Hz, NH conformer 2), 8.08-8.13 (2H, m, 1 × NH2 conformer 
1 and 1 × NH conformer 1), 9.96 (1H, d, J = 4.5 Hz, NH2 conformer 2), 10.25 (1H, d, J = 4.5 Hz, 
NH2 conformer 1); 13C-NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 18.76, 19.30, 25.13, 
25.94, 28.63, 29.13, 36.70, 58.32, 60.91, 71.48, 139.51, 150.63, 161.82, 169.80; conformer 2: 
18.45, 19.52, 25.21, 25.91, 29.04, 29.24, 36.82, 58.78, 61.08, 71.48, 139.60, 150.56, 162.25, 
170.45; MS (ES+) m/z 338 [M+H]+; HRMS calcd for C16H27N5O3 [M+H]+ 338.2187, found 
338.2187. 
3-{[4-Amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino}propan-1-ol (8f). 
Prepared starting from 7f (130 mg, 0.464 mmol), using menthyl nitrite (301 mg, 1.625 mmol). 
The crude product was purified by flash chromatography (gradient from 0/100 to 5/95 
MeOH/CH2Cl2) to give the title compound as a purple solid (80 mg, 56 %). Rf 0.2 (5/95 
MeOH/CH2Cl2); m.p. 168-169 oC; UV max (EtOH/nm): 339.2, 238.2; IR max/cm-1: 3301, 2921, 
2846, 1580. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 2 / 1. 
1H-NMR (500 MHz, DMSO-d6)  (ppm): 1.00-1.32 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 
conformer 2), 1.62-1.91 (16H, m, 6 × C6H11 and 2 × CH2CH2CH2 conformer 1, 6 × C6H11 and 2 
× CH2CH2CH2 conformer 2), 3.33-3.39 (2H, m, CH2NH conformer 1), 3.40-3.50 (6H, m, 2 × 
CH2OH conformer 1, 2 × CH2OH and 2 × CH2NH conformer 2), 4.28 (2H, d, J = 6.4 Hz, CH2O 
conformer 1), 4.36 (2H, d, J = 6.4 Hz, CH2O conformer 2), 4.46 (1H, t, J = 5.1 Hz, OH conformer 
1), 4.49 (1H, t , J = 5.1 Hz, OH conformer 2), 7.85 (1H, d, J = 4.2 Hz, NH2 conformer 2), 8.16-
8.25 (2H, m, 1 × NH2 conformer 1 and 1 × NH conformer 2), 8.33 (1H, t, J = 5.6 Hz, NH conformer 
1), 9.93 (1H, d, J = 4.2 Hz, NH2 conformer 2), 10.29 (1H, d, J = 4.4 Hz, NH2 conformer 1); 13C-
NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 25.14, 25.95, 29.14, 31.94, 36.70, 38.38, 
58.44, 71.49, 139.50, 150.61, 161.31, 169.88; conformer 2: 25.22, 25.93, 29.19, 32.51, 36.86, 
38.55, 58.50, 71.55, 139.85, 150.61, 161.77, 170.17; MS (ES+) m/z 310 [M+H]+; HRMS calcd 
for C14H23N5O3 [M+H]+ 310.1874, found 310.1874. 
tert-Butyl {2-[(4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl)amino]cyclohexyl} 
carbamate (11). Prepared starting from 10 (200 mg, 0.477 mmol), using menthyl nitrite (309 
mg, 1.67 mmol). The crude product was purified by flash chromatography (gradient from 0/100 
to 2/98 MeOH/CH2Cl2) to give the title compound as a purple solid (140 mg, 65 %). Rf 0.4 
 S12 
(2.5/97.5 MeOH/CH2Cl2); m.p. 119-120 oC; UV max (EtOH/nm): 341.0, 237.8, 205.2; IR 
max/cm-1: 3294, 2922, 2851, 1688, 1562. The compound exists as two conformers, conformer 
1 / conformer 2 ratio = 2 / 1. 1H-NMR (500 MHz, DMSO-d6)  (ppm): 0.97-1.42 (36H, m, 5 × 
C6H11, 4 × C6H11 and 9 × CH3 conformer 1, 5 × C6H11, 4 × C6H11 and 9 × CH3 conformer 2), 1.60-
1.92 (20H, m, 6 × C6H11 and 4 × C6H11 conformer 1, 6 × C6H11 and 4 × C6H11 conformer 2), 3.33-
3.41 (2H, m, 1 × CHNHCO conformer 1 and 1 × CHNHCO conformer 2), 3.69-3.85 (2H, m, 1 × 
CHNH conformer 1 and 1 × CHNH conformer 2), 4.20-4.31 (3H, m, 2 × CH2O conformer 1 and 
1 × CH2O conformer 2), 4.35-4.43 (1H, m, CH2O conformer 2), 6.50 (1H, d, J = 8.7 Hz, NHCO 
conformer 2), 6.57 (1H, d, J = 8.7 Hz, NHCO conformer 1), 7.81 (1H, d, J = 4.2 Hz, NH2 
conformer 2), 7.97 (1H, d, J = 8.6 Hz, NH conformer 2), 8.00 (1H, d, J = 8.6 Hz, NH conformer 
1), 8.12 (1H, d, J = 4.2 Hz, NH2 conformer 1), 9.94 (1H, d, J = 4.2 Hz, NH2 conformer 2), 10.27 
(1H, d, J = 4.2 Hz, NH2 conformer 1); 13C-NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 
24.36, 24.55, 25.11, 25.94, 28.07, 29.11, 31.21, 31.99, 36.61, 53.34, 55.12, 71.41, 77.54, 
139.54, 150.62, 155.60, 161.23, 169.85; conformer 2: 24.55, 24.50, 25.23 (C-1, C-5), 25.96, 
28.08, 29.34, 31.24, 32.03, 36.92, 53.30, 55.05, 71.71, 77.54, 139.66, 150.57, 155.60, 161.62, 
169.79; MS (ES+) m/z 449 [M+H]+; HRMS calcd for C22H36N6O4 [M+H]+ 449.2871, found 
449.2861. 
N2-(2-Aminocyclohexyl)-6-cyclohexylmethoxy-5-nitrosopyrimidine-2,4-diamine (8g). To 
11 (138 mg, 0.308 mmol) in CH2Cl2 was added TFA (2 mL / mmol). The reaction was stirred at 
r.t. for 2 h. The solvent was removed under reduced pressure then the free base was triturated 
with saturated aq. NaHCO3 (10 mL) and the product extracted with CH2Cl2. The organic extracts 
were washed with brine and dried (MgSO4). The solvent was removed under reduced pressure 
and the crude product purified by flash chromatography (gradient from 0/100 to 5/95 
MeOH/CH2Cl2) to give the title compound as a purple solid (73 mg, 68 %). Rf 0.25 (5/95 
MeOH/CH2Cl2); m.p. 122-123 oC; UV max (EtOH/nm): 341.0; IR max/cm-1: 3235, 3128, 2918, 
2847, 1561. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 : 2. 
1H-NMR (500 MHz, DMSO-d6)  (ppm): 1.00-1.32 (18H, m, 5 × C6H11 and 4 × C6H11 conformer 
1, 5 × C6H11 and 4 × C6H11 conformer 2), 1.60-1.93 (24H, m, 6 × C6H11, 4 × C6H11 and 2 × NH2CH 
conformer 1, 6 × C6H11, 4 × C6H11 and 2 × NH2CH conformer 2), 2.57-2.65 (2H, m, 1 × CHNH2 
conformer 1 and 1 × CHNH2 conformer 2), 3.54-3.64 (2H, m, 1 × CHNH conformer 1 and 1 × 
CHNH conformer 2), 4.26-4.34 (3H, m, 2 × CH2O conformer 1 and 1 × CH2O conformer 2), 4.43 
(1H, dd, J = 10.6 and 6.2 Hz, CH2O conformer 2), 7.78 (1H, d, J = 4.1 Hz, NH2 conformer 2), 
8.14 (1H, d, J = 4.4 Hz, NH2 conformer 1), 8.20 (1H, d, J = 8.5 Hz, NH conformer 2), 8.28 (1H, 
d, J = 8.5 Hz, NH conformer 1), 9.96 (1H, d, J = 4.1 Hz, NH2 conformer 2), 10.27 (1H, d, J = 4.4 
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Hz, NH2 conformer 1); 13C-NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 24.53, 24.70, 
25.12, 25.94, 29.14, 31.40, 34.27, 36.66, 53.36, 57.24, 71.52, 139.57, 150.68, 161.52, 169.85; 
conformer 2: 24.63, 24.75, 25.19, 25.94, 29.28, 31.88, 34.37, 36.85, 53.19, 57.24, 71.57, 
139.65, 150.58, 161.89, 170.52; MS (ES+) m/z 349 [M+H]+; HRMS calcd for C17H28N6O2 [M+H]+ 
349.2347, found 349.2348. 
2-{1-[4-Amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]piperidin-4-yl}ethan-1-ol 
(8h). Prepared starting from 7h (80 mg, 0.240 mmol), using isopentyl nitrite (80 µL, 70 mg, 0.60 
mmol). The crude product was purified by flash chromatography (gradient from 2/98 to 5/95 
MeOH/CH2Cl2) to give the title compound as a purple solid (60 mg, 69 %). Rf 0.3 (5/95 
MeOH/CH2Cl2); m.p. 204-205 oC; 1H-NMR (300 MHz, DMSO-d6)  (ppm): 0.98-1.33 (9H, m, 5 × 
C6H11 and 4 × CH2 piperidine), 1.33-1.42 (2H, m, CH2CH2CH), 1.57-1.91 (7H, m, 6 × C6H11, 1 × 
CH piperidine), 2.86-3.07 (2H, m, CH2N), 3.41-3.51 (2H, m, CH2OH), 4.31 (2H, d, J = 6.1 Hz, 
CH2O), 4.39 (1H, t, J = 5.0 Hz, OH), 4.68-4.84 (2H, m, CH2N), 8.06 (1H, d, J = 4.4 Hz, NH2) 
10.07 (1H, d, J = 4.4 Hz, NH2); 13C-NMR (75 MHz, DMSO-d6) (ppm): 25.28 (C-1, C-5), 25.95 
(C-6), 29.25 (C-2, C-4), 31.78 (2 × C-piperidine), 32.08 (C-14), 36.91 (C-3), 38.82 (C-17), 44.15 
(C-piperidine), 44.52 (C-piperidine) 58.14(C-18), 71.58(C-7), 139.03 (C-arom.), 150.36 (C-
arom.), 159.06 (C-arom.), 170.13 (C-arom.); MS (ES+) m/z 364 [M+H]+. 
6-(Cyclohexylmethoxy)-5-nitroso-2-(pyrrolidin-1-yl)pyrimidin-4-amine (8i). Prepared 
starting from 7i (100 mg, 0.360 mmol), using isopentyl nitrite (121 µL, 105 mg, 0.91 mmol). The 
crude product was purified by flash chromatography (1/99 MeOH/CH2Cl2) to give the title 
compound as a purple solid (86 mg, 78 %). Rf 0.4 (5/95 MeOH/CH2Cl2); m.p. 172-173 oC; 1H-
NMR (300 MHz, DMSO-d6)  (ppm):  1.04-1.27 (5H, m, C6H11), 1.63-1.83 (10H, m, 6 × C6H11 
and 4 × CH2CH2 pyrrolidine), 3.49-3.53 (2H, m, CH2N pyrrolidine), 3.61-3.66 (2H, m, CH2N 
pyrrolidine), 4.33 (2H, d, J = 6.2 Hz, CH2O), 8.10 (1H, d, J = 4.3 Hz, NH2), 10.13 (1H, d, J = 4.3 
Hz, NH2); 13C-NMR (75 MHz, DMSO-d6)  (ppm): δ 24.58, 24.71, 25.25, 25.95, 29.26, 36.89, 
47.03, 47.23, 71.48, 139.23, 150.27, 158.46, 169.65; MS (ES+) m/z 306 [M+H]+. 
 
General procedure for the synthesis of cyano-NNO-azoxyderivatives. To a stirred 
suspension of the nitroso species (1 eq.) and cyanamide (NH2CN) (3 eq.) in CH3CN, 
(diacetoxyiodo)benzene (IBA) (2 eq.) was added portion-wise at r.t. The reaction mixture 
gradually changed in colour from purple to yellow. After 2 h solvent was removed under reduced 
pressure and the crude product was purified by flash chromatography. 
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4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-[(2-hydroxyethyl)amino]-6-
cyclohexylmethoxypyrimidine (9a). Prepared starting from 8a (58 mg, 0.197 mmol). The 
crude product was purified by flash chromatography (gradient from 2/98 to 10/90 MeOH/CH2Cl2) 
to give the title compound as a yellow solid (33 mg, 50 %). Rf 0.3 (5/95 MeOH/CH2Cl2); m.p. 
161-162oC; UV max (EtOH/nm): 397.6, 247.8, 209.0; IR max/cm-1: 3360, 2924, 2851, 2197, 
1558. The compound exists as two conformers, conformer 1 / Conformer 2 ratio = 2 / 1. 1H-NMR 
(500 MHz, DMSO-d6)  (ppm): 0.99-1.30 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 
conformer 2), 1.60-1.80 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 conformer 2), 3.32-3.37 
(4H, m, 2 × CH2NH conformer 1 and 2 × CH2NH conformer 2), 3.47-3.53 (4H, m, 2 × CH2OH 
conformer 1 and 2 × CH2OH conformer 2), 4.13 (2H, d, J = 6.3 Hz, CH2O conformer 1), 4.19 
(2H, d, J = 6.1 Hz, CH2O conformer 2), 4.67-4.72 (2H, m, 1 × OH conformer 1 and 1 × OH 
conformer 2), 7.83 (1H, t, J = 5.8 Hz, NH conformer 2), 7.93 (1H, t, J = 5.7 Hz, NH conformer 
1), 8.05 (2H, s, NH2 conformer 2), 8.29 (2H, s, NH2 conformer 1); 13C-NMR (125 MHz, DMSO-
d6)  (ppm): conformer 1: 25.17, 22.93, 28.96, 36.49, 43.51, 59.36, 72.20, 106.20, 112.44, 
159.15, 159.18, 163.64; conformer 2: 25.26, 25.93, 29.02, 36.66, 43.74, 59.67, 72.20, 106.14, 
112.36, 158.73, 159.48, 164.23; MS (ES+) m/z 336 [M+H]+; HRMS calcd for C14H21N7O3 [M+H]+ 
336.1779, found 336.1782. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-{[(2S)-1-hydroxypropan-2-yl]amino}-6-
cyclohexylmethoxypyrimidine (9b). Prepared starting from 8b (40 mg, 0.129 mmol). The 
crude product was purified by flash chromatography (gradient from 0/100 to 10/90 
MeOH/CH2Cl2) to give the title compound as a yellow solid (35 mg, 78 %). Rf 0.4 (5/95 
MeOH/CH2Cl2); m.p. 165-167oC; UV max (EtOH/nm): 400.0, 247.6, 207.2; IR max/cm-1: 3346, 
2922, 2850, 2191, 1554. The compound exists as two conformers, conformer 1 / Conformer 2 
ratio = 2 / 1. 1H-NMR (500 MHz, DMSO-d6)  (ppm): 0.98-1.29 (16H, m, 5 × C6H11 and 3 × CH3 
conformer 1, 5 × C6H11 and 3 × CH3 conformer 2), 1.60-1.80 (12H, m, 6 × C6H11 conformer 1 
and 6 × C6H11 conformer 2), 3.33-3.36 (2H, m, 1 × CH2OH conformer 1 and 1 × CH2OH 
conformer 2), 3.33-3.36 (2H, m, 1 × CH2OH conformer 1 and 1 × CH2OH conformer 2), 3.39.3.45 
(2H, m, 1 × CH2OH conformer 1 and 1 × CH2OH conformer 2), 3.97-4.09 (2H, m, 1 × CHNH 
conformer 1 and 1 × CHNH conformer 2), 4.13 (2H, d, J = 6.3 Hz, CH2O conformer 1), 4.19 (2H, 
d, J = 6.0 Hz, CH2O conformer 2), 4.69-4.74 (2H, m, 1 × OH conformer 1 and 1 × OH conformer 
2), 7.68 (1H, d, J = 8.3 Hz, NH conformer 2), 7.79 (1H, d, J = 8.3 Hz, NH conformer 1), 8.01 (2H, 
br. s, NH2 conformer 2), 8.28 (2H, s, NH2 conformer 1); 13C-NMR (125 MHz, DMSO-d6)  (ppm): 
conformer 1: 17.00, 25.17, 25.95, 28.97, 36.49, 48.56, 64.09, 72.23, 106.15, 112.52, 158.64, 
159.22, 163.65; conformer 2: 17.06, 25.28, 25.94, 29.02, 36.68, 49.10, 64.27, 72.23, 106.15, 
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112.52, 158.71, 159.02, 163.69; MS (ES+) m/z 350 [M+H]+; HRMS calcd for C15H23N7O3 [M+H]+ 
350.1935, found 350.1937. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-{[(2R)-1-hydroxypropan-2-yl]amino}-6-
cyclohexylmethoxypyrimidine (9c). Prepared starting from 8c (30 mg, 0.097 mmol). The 
crude product was purified by flash chromatography (gradient from 0/100 to 10/90 
MeOH/CH2Cl2) to give the title compound as a yellow solid (26 mg, 76 %). Rf 0.4 (5/95 
MeOH/CH2Cl2); m.p. 172-173 oC; UV max (EtOH/nm): 400.0, 249.2; IR max/cm-1: 3345, 3300, 
2922, 2849, 2190. The compound exists as two conformers, conformer 1 / Conformer 2 ratio = 
5 / 3. 1H-NMR (500 MHz, CD3OD)  (ppm): 1.06-1.38 (16H, m, 5 × C6H11 and 3 × CH3 conformer 
1, 5 × C6H11 and 3 × CH3 conformer 2), 1.67-1.89 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 
conformer 2), 3.51-3.61 (4H, m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 4.13-
4.21 (4H, m, 2 × CH2O and 1 × CHNH conformer 1, 1 × CHNH conformer 2), 4.25 (1H, d, J = 
6.0 Hz, CH2O conformer 2); 13C-NMR (125 MHz, CD3OD)  (ppm): conformer 1: 17.17, 26.88, 
27.53, 30.71, 38.46, 49.97, 66.21, 74.14, 108.10, 113.47, 160.89, 161.18, 165.69; conformer 2: 
17.41, 26.94, 27.53, 30.74, 38.62, 50.32, 66.21, 74.37, 108.10, 113.29, 160.98, 161.18, 166.34; 
MS (ES+) m/z 350 [M+H]+; HMRS calcd for C15H23N7O3 [M+H]+ 350.1935, found 350.1937. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-{[(2R)-1-hydroxybutan-2-yl]amino}-6-
cyclohexylmethoxypyrimidine (9d). Prepared starting from 8d (170 mg, 0.526 mmol). The 
crude product was purified by flash chromatography (gradient from 0/100 to 5/95 MeOH/CH2Cl2) 
to give the title compound as a yellow solid (90 mg, 47 %). Rf 0.33 (5/95 MeOH/CH2Cl2); m.p. 
152-154 oC; UV max (EtOH/nm): 400.0, 248.0, 207.8; IR max/cm-1: 3341, 2922, 2850, 2192, 
1554. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 / 3. 1H-NMR 
(500 MHz, DMSO-d6)  (ppm): 0.84 (6H, t, J = 7.4 Hz,  3 × CH3 conformer 1 and 3 × CH3 
conformer 2), 1.00-1.28 (10H, m, 5 × C6H11 and 5 × C6H11 conformer 2), 1.36-1.46 (2H, m, 
CH3CH2conformer 1), 1.57-1.78 (14H, m, 6 × C6H11 conformer 1, 6 × C6H11 and 2 × CH3CH2 
conformer 2), 3.36-3.45 (4H, m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 3.82-
3.93 (2H, m, 1 × CHNH conformer 1 and 1 × CHNH conformer 2), 4.14 (2H, d, J = 6.3 Hz, CH2O 
conformer 1), 4.16-4.22 (2H, m, CH2O conformer 2), 4.66 (1H, t, J = 5.5 Hz, OH conformer 1), 
4.67 (1H, t, J = 5.5 Hz, OH conformer 2), 7.65 (1H, d, J = 8.9 Hz, NH conformer 1), 7.76 (1H, d, 
J = 8.9 Hz, NH conformer 1), 8.01 (2H, br. s, NH2, conformer 2), 8.25 (2H, s, NH2, conformer 1); 
13C-NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 10.43, 23.53, 25.18, 25.96, 28.97, 36.50, 
54.31, 62.58, 72.24, 112.54, 159.16, 159.24, 163.60; conformer 2: 10.60, 23.79, 25.27, 25.93, 
29.06, 36.64, 55.04, 62.91, 72.21, 112.45, 158.68, 159.58, 164.12; MS (ES+) m/z 363 [M+H]+; 
HRMS calcd for C16H25N7O3 [M+H]+ 364.21, found 364.21. 
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4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-[(1-hydroxy-3-methylbutan-2-yl)amino]-6-
cyclohexylmethoxypyrimidine (9e). Prepared starting from 8e (60 mg, 0.178 mmol). The 
crude product was purified by flash chromatography (gradient from 0/100 to 10/90 
MeOH/CH2Cl2) to give the title compound as a yellow solid (15 mg, 22%). Rf 0.4 (5/95 
MeOH/CH2Cl2); m.p. 156-157 oC; UV max (EtOH/nm): 400.0, 249.2; IR max/cm-1: 3278, 2920, 
2848, 2187, 1548. The compound exists as two conformers, conformer 1 / conformer 2 ratio = 
5 / 3. 1H-NMR (500 MHz, DMSO-d6)  (ppm): 0.82-0.90 (12H, m, 6 × CH3 conformer 1 and 6 × 
CH3 conformer 2), 0.99-1.30 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 conformer 2), 1.60-
1.81 (12H, m, 6 × C6H11 conformer 1 and 6 × C6H11 conformer 2), 1.83-1.93 (2H, m, 1 × CH(CH3)2 
conformer 1 and 1 × CH(CH3)2 conformer 2), 3.43-3.54 (4H, m, 2 × CH2OH conformer 1 and 2 
× CH2OH conformer 2), 3.81-3.91 (2H, m, 1 × CHNH conformer 1 and 1 × CHNH conformer 2), 
4.12-4.18 (3H, m, 2 × CH2O conformer 1 and 1 × CH2O conformer 2), 4.21 (1H, dd, J = 10.7 
and 5.7 Hz, CH2O conformer 2), 4.54-4.61 (2H, m, 1 × OH conformer 1 and 1 × OH conformer 
2), 7.66 (1H, d, J = 9.2 Hz, NH conformer 2), 7.77 (1H, d, J = 9.2 Hz, NH conformer 1), 8.00 (2H, 
s, NH2 conformer 2), 8.24 (2H, s, NH2 conformer 1); 13C-NMR (125 MHz, DMSO-d6)  (ppm): 
conformer 1: 18.67, 19.35, 25.18, 25.95, 28.64, 28.97, 36.52, 58.06, 60.94, 72.23, 106.09, 
112.54, 159.09, 159.51, 163.57; conformer 2: 18.40, 19.53, 25.25, 25.91, 28.64, 29.06, 36.59, 
58.61, 61.10, 72.19, 106.27, 112.43, 158.65, 159.80, 164.04; MS (ES+) m/z 378 [M+H]+; HRMS 
calcd for C17H27N7O3 [M+H]+ 378.2248, found 378.2249. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-[(3-hydroxypropyl)amino]-6-
cyclohexylmethoxypyrimidine (9f). Prepared starting from 8f (65 mg, 0.210 mmol). The crude 
product was purified by flash chromatography (gradient from 20/80 to 40/60 EtOAc /CH2Cl2) to 
give the title compound as a yellow solid (12 mg, 16 %). Rf 0.3 (5/95 MeOH/CH2Cl2); m.p. 171-
172 oC; UV max (EtOH/nm): 401.0; IR max/cm-1: 3350, 3144, 2922, 2850, 2193, 1556. The 
compound exists as two conformers, conformer 1 / conformer 2 ratio = 5 / 3. 1H-NMR (500 MHz, 
DMSO-d6)  (ppm): 0.98-1.31 (10H, m, 5 × C6H11 conformer 1 and 5 × C6H11 conformer 2), 1.61-
1.82 (16H, m, 6 × C6H11 and 2 × CH2CH2CH2 conformer 1, 6 × C6H11 and 2 × CH2CH2CH2 
conformer 2), 3.32-3.38 (4H, m, 2 × CH2NH conformer 1 and 2 × CH2NH conformer 2), 3.41-
3.48 (4H, m, 2 × CH2OH conformer 1 and 2 × CH2OH conformer 2), 4.12 (2H, d, J = 6.3 Hz, 
CH2O conformer 1), 4.21 (2H, d, J = 5.8 Hz, CH2O conformer 2) 4.39-4.49 (2H, m, 1 × OH 
conformer 1 and 1 × OH conformer 2), 7.90 (1H, t, J = 5.8 Hz, NH conformer 2), 8.00 (1H, t, J = 
5.8 Hz, NH conformer 1), 8.03 (2H, br. s, NH2 conformer 2), 8.30 (2H, s, NH2 conformer 1); 13C-
NMR (125 MHz, DMSO-d6)  (ppm): conformer 1: 25.18, 25.94, 28.96, 31.97, 36.50, 38.19, 
58.47, 72.22, 106.16, 112.50, 159.01, 159.19, 163.62; conformer 2: 25.25, 25.94, 29.02, 32.44, 
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36.63, 38.41, 58.51, 72.22, 106.34, 112.41, 158.73, 159.34, 164.22; MS (ES+) m/z 350 [M+H]+; 
HRMS calcd for C15H23N7O3  [M+H]+ 350.1935, found 350.1938. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-[(2-aminocyclohexyl)amino]-6-
cyclohexylmethoxypyrimidine (9g). Prepared starting from 8g (70 mg, 0.20 mmol), 
cyanamide (25 mg, 0.60 mmol), IBA (129 mg, 0.40 mmol) and CH3CN (2 mL). Purification by 
flash chromatography (gradient from 0/100 to 30/70 MeOH/CH2Cl2) gave a mixture of products. 
A second flash chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2 + HCOOH 0.1 %) 
was performed to obtain the title compound as a yellow solid (10 mg, 13 %). Rf 0.2 (20/80 
MeOH/CH2Cl2); m.p. 203-204 oC dec.; UV max (EtOH/nm): 400.0, 248.2, 209.6; IR max/cm-1: 
3293, 3145, 2924, 2853, 2191, 1555. 
1
H-NMR Spectrum: The compound exists as two 
conformers, conformer 1 / conformer 2 ratio = 5 / 3. 1H-NMR (500 MHz, CD3OD)  (ppm): 1.07-
1.52 (18H, m, 5 × C6H11 and 4 × C6H11 conformer 1, 5 × C6H11 and 4 × C6H11 conformer 2), 1.66-
2.14 (20H, m, 6 × C6H11 and 4 × C6H11 conformer 1, 6 × C6H11 and 4 × C6H11 conformer 2), 2.92-
2.99 (2H, m, 1 × CHNH2 conformer 1 and 1 × CHNH2 conformer 2), 3.88-3.95 (2H, m, 1 × CHNH 
conformer 1 and 1 × CHNH conformer 2), 4.21 (2H, d, J = 6.2 Hz, CH2O conformer 1), 4.26-
4.32 (1H, m, CH2O conformer 2), 4.32-4.37 (1H, m, CH2O conformer 2); 13C-NMR (125 MHz, 
CD3OD)  (ppm): conformer 1: 25.59, 27.72, 26.88, 27.54, 30.72, 32.93, 33.14, 38.46, 55.75, 
59.57, 74.20, 113.43, 117.69, 161.32, 161.42, 165.80; conformer 2: 25.54, 27.72, 26.94, 27.54, 
30.78, 32.78, 33.14, 38.63, 55.96, 58.81, 74.57, 113.19, 117.34, 161.06, 161.50, 166.41; MS 
(ES+) m/z 389 [M+H]+; HRMS calcd for C18H28N8O2 [M+H]+ 389.2408, found 389.2408. 
4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-[4-(2-hydroxyethyl)piperidin-1-yl]-6-
cyclohexylmethoxypyrimidine (9h). Prepared starting from 8h (110 mg, 0.30 mmol). 
Purification by flash chromatography (20/80 acetone/PE) gave a mixture of products. A second 
flash chromatography (gradient from 0/100 to 10/90 MeOH/CH2Cl2) was performed to obtain the 
title compound as a yellow solid (20 mg, 16%). Rf 0.4 (5/95 MeOH/CH2Cl2); m.p. 135-137 oC 
(dec.); UV max (EtOH/nm): 400.0; IR max/cm-1: 3483, 3441, 3355, 2922, 2852, 2190. 1H-NMR 
(300 MHz, DMSO-d6)  (ppm): 0.94-1.43 (9H, m, 5 × C6H11 and 4 × CH2 piperidine), 1.56-1.85 
(9H, m, 2 × CH2CH2CH, 6 × C6H11 and 1 × CH piperidine), 2.81-3.04 (2H, m, CH2N), 3.39-3.55 
(2H, m, CH2OH), 4.16 (2H, d, J = 5.3 Hz, CH2O), 4.40 (1H, t, J = 4.5 Hz, OH), 4.55-4.75 (2H, m, 
CH2N), 8.24 (2H, s, NH2); 13C-NMR (75 MHz, DMSO-d6)  (ppm): 25.34, 25.98, 29.08, 31.76, 
32.08, 36.69, 43.86, 44.23, 58.14, 72.33, 105.82, 112.55, 156.99, 158.88, 163.89; MS (ES+) m/z 
404 [M+H]+; HRMS calcd for C19H29N7O3 [M+H]+ 404.2405, found 404.2403. 
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4-Amino-5-[(Z)-cyano-NNO-azoxy]-2-(pyrrolidin-1-yl)-6-cyclohexylmethoxypyrimidine 
(9i). Prepared starting from 8i (40 mg, 0.131 mmol). The crude product was purified by flash 
chromatography (gradient from 5/95 to 20/80 acetone/PE) to give the title compound as a yellow 
solid (18 mg, 40%). Rf 0.5 (5/95 MeOH/CH2Cl2); m.p. 181-183 oC; UV max (EtOH/nm): 399.8, 
258.4; IR max/cm-1: 3464, 3339, 2937, 2851,2183, 1554. 1H-NMR (500 MHz, DMSO-d6)  (ppm): 
0.99-1.29 (5H, m, C6H11), 1.60-1.81 (6H, m, C6H11), 1.86-1.95 (4H, m, CH2CH2pyrrolidine), 3.46-
3.52 (2H, m, CH2N pyrrolidine), 3.53-3.59 (2H, m, CH2N pyrrolidine), 4.19 (2H, d, J = 6.0 Hz, 
CH2O), 8.24 (2H, s, NH2); 13C-NMR (125 MHz, DMSO-d6)  (ppm): 24.63, 24.76, 25.26, 25.94, 
29.06, 36.64, 46.74, 46.88, 72.19, 106.10, 112.47, 156.32, 158.67, 163.40; MS (ES+) m/z 346 
[M+H]+; HRMS calcd for C16H23N7O2 [M+H]+ 346.1986 found 346.1988.  
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